A.M. Moody - Concepedia

Author

A.M. Moody

University of Cambridge

Also Known As

A M Moody, A Moody, A. M. Moody, A. Moody, A.M. Moody, Anne M. Moody, Anne Margaret Moody

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Cambridge Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital West Suffolk Hospital Cancer Research UK

About

A.M. Moody is an author at University of Cambridge specializing in medicine, breast cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	902
2	Health Sciences	6	6	508
3	Nursing	1	1	39
4	Family Medicine	1	1	32
5	Immunology	1	1	70

A.M. Moody

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity A.M. Moody, W. P. M. Mayles, Judith M. Bliss, Radiotherapy and Oncology Radiation TherapyBreast SizeBrachytherapyRadiotherapy Dose InhomogeneityBreast Cancer	1994	282
Randomized Controlled Trial of Intensity-Modulated Radiotherapy for Early Breast Cancer: 5-Year Results Confirm Superior Overall Cosmesis Mukesh B. Mukesh, Gillian C. Barnett, Jennifer Wilkinson, Journal of Clinical Oncology	2013	228
Randomized Controlled Trial of Forward-Planned Intensity Modulated Radiotherapy for Early Breast Cancer: Interim Results at 2 Years Gillian C. Barnett, Jennifer Wilkinson, A.M. Moody, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyEarly Breast CancerControlled TrialMedicineInterim Results	2011	115
A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: Baseline characteristics and dosimetry results Gillian C. Barnett, Jennifer Wilkinson, A.M. Moody, Radiotherapy and Oncology OncologyForward-planned RadiotherapyRadiation TherapyEarly Breast CancerBreast Cancer	2009	113
The Cambridge Breast Intensity-modulated Radiotherapy Trial: Patient- and Treatment-related Factors that Influence Late Toxicity Gillian C. Barnett, Jennifer Wilkinson, A.M. Moody, Clinical Oncology Adaptive RadiotherapyRadiation MedicineOncologyRadiation TherapyInfluence Late Toxicity	2011	93
LIMBIC ENCEPHALITIS ASSOCIATED WITH ANTIBODIES TO THE NMDA RECEPTOR IN HODGKIN LYMPHOMA Michael S. Zandi, Sarosh R. Irani, George Follows, Neurology Neurological DisorderImmunodeficienciesImmunologyPathologyImmunotherapy	2009	70
Association of breast tumour bed seroma with post-operative complications and late normal tissue toxicity: Results from the Cambridge Breast IMRT trial M. Mukesh, Gillian C. Barnett, J. Cumming, European Journal of Surgical Oncology Surgical OncologyBreast OncologyMedicinePost-operative ComplicationsBreast Cancer	2012	47
Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: Results from the Cambridge Breast IMRT trial Mukesh B. Mukesh, Wendi Qian, Jennifer Wilkinson, Radiotherapy and Oncology NursingField-in Field ImrtPatient SelectionClinical EndpointPatient Safety	2014	39
Is community treatment best? a randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgery Pippa Corrie, A.M. Moody, G. Armstrong, British Journal of Cancer	2013	39
A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications Pippa Corrie, Ravi Bulusu, Charles B. Wilson, British Journal of Cancer	2012	37

Page 1